Loading...
XSHE
300981
Market cap622mUSD
Jul 10, Last price  
10.09CNY
1D
2.13%
1Q
-27.72%
IPO
-81.50%
Name

Zhonghong Pulin Medical Products Co Ltd

Chart & Performance

D1W1MN
XSHE:300981 chart
P/E
P/S
1.82
EPS
Div Yield, %
2.53%
Shrs. gr., 5y
1.92%
Rev. gr., 5y
-13.53%
Revenues
2.37b
-3.40%
550,611,138585,048,821604,083,100710,080,600951,153,300967,534,1271,170,814,0394,778,406,8714,909,310,9364,909,310,9351,572,568,5131,572,568,5132,105,249,6052,456,650,7142,373,206,803
Net income
-112m
L+28.98%
3,035,80724,917,18942,313,40038,214,70065,010,49956,669,36789,266,0232,663,518,7222,341,903,8792,341,903,88466,916,00966,916,015-130,870,575-87,128,892-112,383,173
CFO
4m
-97.97%
13,365,927133,333,00092,230,044102,368,25296,027,72223,766,227184,382,5612,719,677,0592,362,497,606106,707,621140,676,906183,912,3423,735,684
Dividend
Jun 27, 20250.25 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhonghong Pulin Medical Products Co., Ltd. is involved in the complete process of plastic glove production, from initial research and development to manufacturing and sales. The company's offerings specifically comprise disposable vinyl and nitrile gloves, which are designed for application in a variety of fields, including the healthcare sector, food handling, and electronics manufacturing. Established in 2010, the firm's main base of operations is located in Tangshan, China. It functions as a subsidiary under the corporate structure of Zhonghong Pulin Group Co., Ltd.
IPO date
Apr 27, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT